COMBINATIONS OF CTPS1 AND BCL2 INHIBITORS FOR CANCER

Abstract: the invention provides inter alia methods of treating cancer comprising administering to a subject a cytidine triphosphate synthase 1 (ctps1) inhibitor and a b-cell lymphoma 2 (bcl2) inhibitor.

Inventor(s): Philip BEER, David CHIRON, Andrew PARKER, Catherine PELLAT-DECEUNYNCK

CPC Classification: A61K31/506 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250177394